• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在具有1型人类免疫缺陷病毒中和活性的血清反应阴性个体中发现的抗细胞抗体。

Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity.

作者信息

Lopalco L, Pastori C, Cosma A, Burastero S E, Capiluppi B, Boeri E, Beretta A, Lazzarin A, Siccardi A G

机构信息

DIBIT and Infectious Diseases Clinic, San Raffaele Scientific Institute, Milan, Italy.

出版信息

AIDS Res Hum Retroviruses. 2000 Jan 20;16(2):109-15. doi: 10.1089/088922200309458.

DOI:10.1089/088922200309458
PMID:10659050
Abstract

Despite repeated exposures to HIV-1, some individuals remain seronegative. This study reports that sera from a fraction of exposed seronegative (ESN) subjects showed HIV-neutralizing activity; 5 of 17 ESN sera and none of 17 controls neutralized two different HIV-1 primary isolates (range of neutralizing titers: 1/20 to 1/60). The neutralizing activity was associated with the IgG fraction of 4 of 4 neutralizing ESN sera. Moreover, in 11 of 17 and 9 of 17 ESN sera (but none of the control sera) we found antibodies against HLA class I and CD4, respectively. One of the ESN sera (EU22) neutralized efficiently the primary virus derived from the seropositive partner and showed a good broadly cross-reactive neutralization. Immunoadsorption of two IgG fractions from EU19 and EU22 on peripheral blood mononuclear cells (PBMC) removed virus-neutralizing antibodies. The correlations between the ESN status and neutralizing activity (p<0.05), anti-HLA antibodies (p<0.0002), and anti-CD4 antibodies (p<0.001) were statistically significant. However, there was no statistically significant correlation between neutralizing activity and either anti-HLA or anti-CD4 antibodies. It can therefore be said that exposure to HIV-1 without seroconversion is, in some individuals, associated with HIV-neutralizing antibodies (not directed against viral antigens) and/or with anti-cell autoantibodies, which are possibly specific for cellular antigens involved in the infection/entry process.

摘要

尽管多次接触HIV-1,但一些个体仍保持血清学阴性。本研究报告称,一部分暴露后血清学阴性(ESN)受试者的血清显示出HIV中和活性;17份ESN血清中的5份以及17份对照血清中均无中和两种不同HIV-1原始毒株的能力(中和效价范围:1/20至1/60)。中和活性与4份具有中和作用的ESN血清中的IgG组分相关。此外,在17份ESN血清中的11份以及17份ESN血清中的9份(但对照血清中均无)中,我们分别发现了针对HLA I类分子和CD4的抗体。其中一份ESN血清(EU22)能有效中和来自血清学阳性伴侣的原始病毒,并表现出良好的广泛交叉反应中和能力。用EU19和EU22的两个IgG组分对外周血单核细胞(PBMC)进行免疫吸附可去除病毒中和抗体。ESN状态与中和活性(p<0.05)、抗HLA抗体(p<0.0002)和抗CD4抗体(p<0.001)之间的相关性具有统计学意义。然而,中和活性与抗HLA或抗CD4抗体之间均无统计学显著相关性。因此可以说,在一些个体中,未发生血清转化的HIV-1暴露与HIV中和抗体(并非针对病毒抗原)和/或抗细胞自身抗体相关,这些抗体可能针对感染/进入过程中涉及的细胞抗原具有特异性。

相似文献

1
Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity.在具有1型人类免疫缺陷病毒中和活性的血清反应阴性个体中发现的抗细胞抗体。
AIDS Res Hum Retroviruses. 2000 Jan 20;16(2):109-15. doi: 10.1089/088922200309458.
2
CCR5-reactive antibodies in seronegative partners of HIV-seropositive individuals down-modulate surface CCR5 in vivo and neutralize the infectivity of R5 strains of HIV-1 In vitro.HIV血清阳性个体的血清阴性伴侣体内的CCR5反应性抗体可在体内下调表面CCR5,并在体外中和HIV-1 R5毒株的感染性。
J Immunol. 2000 Mar 15;164(6):3426-33. doi: 10.4049/jimmunol.164.6.3426.
3
Induction of murine mucosal CCR5-reactive antibodies as an anti-human immunodeficiency virus strategy.诱导小鼠黏膜CCR5反应性抗体作为一种抗人类免疫缺陷病毒的策略。
J Virol. 2005 Jun;79(11):6848-58. doi: 10.1128/JVI.79.11.6848-6858.2005.
4
Anti-CD4 antibodies are associated with HIV-1 seroconversion and may be detectable before anti-HIV-1 antibodies. The Multicenter AIDS Cohort Study.抗CD4抗体与HIV-1血清转化相关,且可能在抗HIV-1抗体出现之前就能检测到。多中心艾滋病队列研究。
AIDS Res Hum Retroviruses. 1992 Nov;8(11):1919-27. doi: 10.1089/aid.1992.8.1919.
5
Identification and characterization of broadly cross-reactive neutralizing antibodies in patients infected with HIV-1 B'/C recombinant (CRF07_BC).鉴定和分析感染 HIV-1 B'/C 重组型(CRF07_BC)病毒的患者体内广谱交叉中和抗体。
Mol Med Rep. 2012 May;5(5):1311-7. doi: 10.3892/mmr.2012.790. Epub 2012 Feb 14.
6
Assessing human alloimmunization as a strategy for inducing HIV type 1 neutralizing anti-HLA responses.评估人类同种免疫作为诱导1型人类免疫缺陷病毒中和性抗人 HLA 反应的一种策略。
AIDS Res Hum Retroviruses. 2003 Nov;19(11):957-65. doi: 10.1089/088922203322588305.
7
Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells.与CCR5第一细胞外环反应的天然粘膜抗体可抑制HIV-1跨人上皮细胞的转运。
AIDS. 2007 Jan 2;21(1):13-22. doi: 10.1097/QAD.0b013e328011049b.
8
Secretory IgA specific for MPER can protect from HIV-1 infection in vitro.针对 MPER 的分泌型 IgA 可在体外预防 HIV-1 感染。
AIDS. 2013 Jul 31;27(12):1992-5. doi: 10.1097/QAD.0b013e3283632ea1.
9
Autoantibodies to CD4 in HIV type 1-exposed seronegative individuals.1型人类免疫缺陷病毒暴露后血清学阴性个体中针对CD4的自身抗体。
AIDS Res Hum Retroviruses. 1996 Mar 1;12(4):273-80. doi: 10.1089/aid.1996.12.273.
10
Anti-V3/Glycan and Anti-MPER Neutralizing Antibodies, but Not Anti-V2/Glycan Site Antibodies, Are Strongly Associated with Greater Anti-HIV-1 Neutralization Breadth and Potency.抗V3/聚糖和抗膜近端外部区域(MPER)中和抗体,而非抗V2/聚糖位点抗体,与更强的抗HIV-1中和广度和效力密切相关。
J Virol. 2015 May;89(10):5264-75. doi: 10.1128/JVI.00129-15. Epub 2015 Feb 11.

引用本文的文献

1
Excess BAFF May Impact HIV-1-Specific Antibodies and May Promote Polyclonal Responses Including Those from First-Line Marginal Zone B-Cell Populations.过量的B细胞激活因子(BAFF)可能影响HIV-1特异性抗体,并可能促进多克隆反应,包括来自一线边缘区B细胞群体的反应。
Curr Issues Mol Biol. 2023 Dec 19;46(1):25-43. doi: 10.3390/cimb46010003.
2
Alloimmunity to Class 2 Human Leucocyte Antigens May Reduce HIV-1 Acquisition - A Nested Case-Control Study in HIV-1 Serodiscordant Couples.同种异体免疫对 2 类人类白细胞抗原可能会降低 HIV-1 的感染风险——HIV-1 血清学不一致的夫妇中嵌套病例对照研究。
Front Immunol. 2022 Mar 24;13:813412. doi: 10.3389/fimmu.2022.813412. eCollection 2022.
3
An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques.
一种HIV gp120-CD4免疫原不会在食蟹猴中引发自身免疫抗体反应。
Clin Vaccine Immunol. 2016 Jul 5;23(7):618-27. doi: 10.1128/CVI.00115-16. Print 2016 Jul.
4
Mucosal correlates of protection in HIV-1-exposed sero-negative persons.HIV-1暴露血清阴性者中保护作用的黏膜相关因素。
Am J Reprod Immunol. 2014 Aug;72(2):219-27. doi: 10.1111/aji.12202. Epub 2014 Jan 16.
5
CCR5: From Natural Resistance to a New Anti-HIV Strategy.CCR5:从天然抵抗到新的抗 HIV 策略。
Viruses. 2010 Feb;2(2):574-600. doi: 10.3390/v2020574. Epub 2010 Feb 5.
6
Serodeconversion of HIV antibody-positive AIDS patients following treatment with V-1 Immunitor.V-1免疫调节剂治疗后HIV抗体阳性艾滋病患者的血清学转换
J Biomed Biotechnol. 2009;2009:934579. doi: 10.1155/2009/934579. Epub 2008 Oct 28.
7
Excretion of human immunodeficiency virus type 1 through polarized epithelium by immunoglobulin A.1型人类免疫缺陷病毒通过免疫球蛋白A经极化上皮细胞排泄
J Virol. 2008 Dec;82(23):11526-35. doi: 10.1128/JVI.01111-08. Epub 2008 Oct 1.
8
HLA-C increases HIV-1 infectivity and is associated with gp120.人类白细胞抗原C(HLA - C)可增加HIV - 1的传染性,并与糖蛋白120(gp120)相关。
Retrovirology. 2008 Aug 1;5:68. doi: 10.1186/1742-4690-5-68.
9
Quantitation of HLA proteins incorporated by human immunodeficiency virus type 1 and assessment of neutralizing activity of anti-HLA antibodies.1型人类免疫缺陷病毒整合的HLA蛋白定量及抗HLA抗体中和活性评估。
J Virol. 2008 Jan;82(1):428-34. doi: 10.1128/JVI.00638-07. Epub 2007 Oct 17.
10
Inhibition of HIV-1 entry by antibodies: potential viral and cellular targets.抗体对HIV-1进入的抑制作用:潜在的病毒和细胞靶点。
J Intern Med. 2007 Jul;262(1):26-43. doi: 10.1111/j.1365-2796.2007.01820.x.